Stem cell-based therapies, also known as cell replacement therapies or regenerative medicine, provide the means to cure a host of diseases and disorders. There are various types of stem cells (adult stem cells, human embryonic stem cells, induced pluripotent stem cells, rat neural stem cells) available as therapeutic products in different applications (cardiology, diabetes, hematology, neurology, oncology, and orthopedics diseases and disorders). Bone marrow derived stem cells have been used for various therapeutic purposes such as such as thalassemia, aplastic anemia, and sickle cell anemia, and leukemia. Umbilical cord or cord blood is considered a rich source of stem cells which are derived mesenchymal stem cells that are used in regenerative therapies for various medical conditions including diabetes, Alzheimer’s disease, soft tissue repair, etc.
The stem cells market report estimates the market size (Revenue USD million – 2014 to 2021) and composition of this market based on different stem cell technologies such as stem cells isolation, culture, cryopreservation, IVF, etc., stem cell types (adult stem cells, human embryonic stem cells, induced pluripotent stem cells, rat neural stem cells) available as therapeutic products and different applications (cardiology, diabetes, hematology, neurology, oncology, and orthopedics) available in the global market and also forecasts growth trends (CAGR% – 2017 to 2021).
The global stem cells market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global stem cells market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global stem cells market and included in this report are Advanced Cell Technology, Inc., Aastrom Biosciences, Inc., BetaStem Therapeutics, Inc., Cardio3 Biosciences, Cellular Dynamics International (CDI), Cynata Therapeutics, Inc., Cytori Therapeutics, Inc., Dendreon Corp., Gamida Cell Ltd., Genea Biocell Pty. Ltd., Lonza Group AG, MaxCyte, Medipost, Mesoblast Ltd., Osiris Therapeutics, Inc., Organovo, Pluristem Therapeutics, Inc., Regeneus Ltd., STEMCELL Technologies, Inc., TerumoBCT, Thermo Fisher Scientific and VIACYTE, Inc.